These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21570676)

  • 21. Timing and delay discounting in attention-deficit/hyperactivity disorder: A translational approach.
    Fox AE; Nicholson AM; Singha D; Thieret BAS; Ortiz M; Visser EJ
    Dev Psychobiol; 2023 Jul; 65(5):e22399. PubMed ID: 37338253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
    Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential sensitivity to the acute and sensitizing behavioral effects of methylphenidate as a function of strain in adolescent and young adult rats.
    Yetnikoff L; Arvanitogiannis A
    Behav Brain Funct; 2013 Oct; 9():38. PubMed ID: 24134881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study.
    Carboni E; Silvagni A; Valentini V; Di Chiara G
    Neurosci Biobehav Rev; 2003 Nov; 27(7):653-9. PubMed ID: 14624809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate.
    Yang PB; Amini B; Swann AC; Dafny N
    Brain Res; 2003 May; 971(2):139-52. PubMed ID: 12706230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2011 Mar; 7():6. PubMed ID: 21450079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.
    Somkuwar SS; Darna M; Kantak KM; Dwoskin LP
    Biochem Pharmacol; 2013 Jul; 86(2):309-16. PubMed ID: 23623751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.
    Harvey RC; Jordan CJ; Tassin DH; Moody KR; Dwoskin LP; Kantak KM
    Behav Brain Res; 2013 May; 244():38-47. PubMed ID: 23376704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.
    Jordan CJ; Harvey RC; Baskin BB; Dwoskin LP; Kantak KM
    Drug Alcohol Depend; 2014 Jul; 140():25-32. PubMed ID: 24811203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential locomotor responses in male rats from three strains to acute methylphenidate.
    Amini B; Yang PB; Swann AC; Dafny N
    Int J Neurosci; 2004 Sep; 114(9):1063-84. PubMed ID: 15370174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants.
    Sagvolden T; Metzger MA; Schiørbeck HK; Rugland AL; Spinnangr I; Sagvolden G
    Behav Neural Biol; 1992 Sep; 58(2):103-12. PubMed ID: 1360797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats differ in performance on a win-shift task in the water radial arm maze.
    Clements KM; Wainwright PE
    Behav Brain Res; 2006 Feb; 167(2):295-304. PubMed ID: 16293322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug reinforcement in a rat model of attention deficit/hyperactivity disorder--the Spontaneously Hypertensive Rat (SHR).
    Vendruscolo LF; Izídio GS; Takahashi RN
    Curr Drug Abuse Rev; 2009 May; 2(2):177-83. PubMed ID: 19630747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
    Dela Peña I; Shen G; Shi WX
    Eur J Pharmacol; 2021 Feb; 892():173826. PubMed ID: 33347825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of d-amphetamine on short- and long-term memory in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.
    Meneses A; Ponce-Lopez T; Tellez R; Gonzalez R; Castillo C; Gasbarri A
    Behav Brain Res; 2011 Jan; 216(1):472-6. PubMed ID: 20813138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task.
    Thanos PK; Ivanov I; Robinson JK; Michaelides M; Wang GJ; Swanson JM; Newcorn JH; Volkow ND
    Pharmacol Biochem Behav; 2010 Jan; 94(3):374-9. PubMed ID: 19818805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol withdrawal and amphetamine co-use in an animal model for attention deficit hyperactivity disorder.
    Shah PM; Pillarella NR; Telatin M; Negroni NC; Baals JN; Haemmerle GL; Pillari BT; Rhoads DE
    Am J Drug Alcohol Abuse; 2024 May; 50(3):334-344. PubMed ID: 38833614
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD).
    Chelaru MI; Yang PB; Dafny N
    Behav Brain Res; 2012 Jan; 226(1):8-17. PubMed ID: 21889544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.